A University of Leeds researcher is developing a new eye lens, made from the same material found in smartphone and TV screens, which could restore long-sightedness in older people.
Make the Diagnosis: Ocular Oddity
(MedPage Today) — Case Findings: A 45-year-old male presents with blurred vision in the left eye. He has no prior history of eye disease. The results of a fundoscopy showed lines of crystalline deposits following the path of the retinal arterioles.
…
Inotek Pharmaceuticals Initiates Dosing of MATRx-1, the First Pivotal Phase 3 Clinical Trial of Trabodenoson, a Novel Treatment for Glaucoma
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Initiates Dosing of MATRx- 1, the First Pivotal Phase 3 Clinical Trial of Trabodenoson, a Novel Treatment for Glaucoma
Is the first commercial gene therapy product within sight?
Highly anticipated phase III clinical trial results of Spark Therapeutics’s gene therapy to treat visual impairment are due by year-end and could have profound implications for the broader gene…
Complications of Anesthesia for Cataract Surgery: Rare But Possible
Although rates are trending down, serious complications remain possible with local anesthesia for cataract surgery, according to a new study. Reuters Health Information
Mechanical epithelial removal in cross-linking may have fewer short-term complications
Corneal collagen cross-linking performed with transepithelial phototherapeutic keratectomy may result in more short-term complications compared with mechanical epithelial removal in keratoconus patients, according to a study.The nonrandomized retrospec…